Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2014 / Cilt: 40 - Sayı: 3

Predictive values for extracapsular extension in prostate cancer patients with PSA values below 10 ng/mL

Pages
130–133
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, these results must be considered in preoperative evaluation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to determine predictive values of extracapsular extension (ECE) in patients who had un - dergone radical retropubic prostatectomy (RRP) with prostate-specifc antigen (PSA) values below 10 ng/mL.
📊
Key Findings & Data:Material and methods: We retrospectively scanned data of 167 patients with PSA values below 10 ng/ mL who had undergone radical retropubic prostatectomy (RRP) between April 2004 and August 2011 in our clinic.
💡
Conclusion & Impact:Therefore, these results must be considered in preoperative evaluation.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to determine predictive values of extracapsular extension (ECE) in patients who had un - dergone radical retropubic prostatectomy (RRP) with prostate-specifc antigen (PSA) values below 10 ng/mL. Material and methods: We retrospectively scanned data of 167 patients with PSA values below 10 ng/ mL who had undergone radical retropubic prostatectomy (RRP) between April 2004 and August 2011 in our clinic. Age, PSA, PSA ratio, PSA density, digital rectal examination (DRE) fndings, biopsy total Glea - son score, perineural invasion (PNI), and lymphovascular invasion (LVI) were analyzed. Parameters of the groups with or without extracapsular extension in RRP pathology specimens were compared. Results: The mean age of patients was 66.4±12.3 years. According to histopathological analysis of the spec - imens of RRP of 167 patients, 45 (26.9%) had extracapsular extension (pT3-4) (Group 1); 122 (73.1%) were confned to the prostate (pT2) (Group 2). The mean PSA level was high in Group 1 (p=0.114), PSA ratio was higher in Group 2 (p=0.09). PSA density was 0.17 in Group 1 and 0.24 in Group 2 (p=0.03). DRE positivity was 53.3% and 57.1%, respectively (p=0.71). Biopsy total Gleason score was higher in Group 1 than Group 2 with a statistically signifcant difference (p=0.04). A statistically signifcant difference was found between the rates of PNI and LVI (28.9% and 1.63%, respectively) (p=0.002). There was no statistically signifcant difference between both groups as for surgical margin positivity (p=0.18). Conclusion: In PCa patients with PSA values below 10 ng/mL, PSA density, lymphovascular invasion and biopsy Gleason total score were statistically signifcant in predicting extracapsular invasion. Therefore, these results must be considered in preoperative evaluation.

🔖

Cite This Article

SERTKAYA, Z., ÖZTÜRK, M. İ., KOCA, O., GÜNEŞ, M., KARAMAN, M. İ. (2014). Predictive values for extracapsular extension in prostate cancer patients with PSA values below 10 ng/mL. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 40 - Sayı: 3, 130–133. https://ajindex.com/articles/328024

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Parker SL, Tong T, Bolden SL. Cancer statistics. Cancer J Clin 1997
  2. [CrossRef] 2. Andriole GL, Crawford ED, Grubb III RL, Buys SS, Chia D, Church TR. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009
  3. [CrossRef] 3. Silverberg E, Boring CC, Squires TS. Cancer statistic. Cancer 1990
  4. Catalona WS, Smiths DS, Ratliff TL. Detection of organ-confined prostate cancer is increased through prostate- specific antigen based screening. JAMA 1993
  5. [CrossRef] 5. Mettlin C, Lee F, Drago J. Findings on the detection of early prostate cancer in 2425 men. Cancer 1991
  6. [CrossRef] 6. Bensalah K, Lotan J, Karam JA, Sheriat SF. New sirculating biomarkers for prostate cancer. Prostate Cancer Prostatic Dis 2008
  7. [CrossRef] 7. D’amico AV, Whittington R, Malkowicz SB. Clinical Utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol 2000
  8. Partin AW, Kattan MW, Subong EN. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. J Am Med Assoc 1997
  9. [CrossRef] 9. Grossklaus DJ, Coffey CS, Shappell SB. Percent of cancer in biop - sys et predicts pathological findings after prostatectomy. J Urol 2002
  10. [CrossRef] 10. Walsh PC. Anatomic radical retropubic prostatectomy
  11. in Walsh PC, Retik AB, Vaughan ED Jr., Wein AJ (eds): Campbell’s Urology 1998, ed 7, Philadelphia, vol 3, 2565-88. 11. Seaman EK, Whang IS, Cooner W, Olsson CA, Benson MC. Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostate. Urology 1994
  12. [CrossRef] 12. Chang JS, Choi H, Chang YS, Kim JB, Oh MM, Moon DG, et al. Prostate-specific antigen density as a powerful predictor of extracapsular extension and positive surgical margin in radical prostatectomy patients with prostate-specific antigen levels of less than 10 ng/ml. Korean J Urol 2011
  13. [CrossRef] 13. Ishida M, Nakashima J, Hashiguchi A, Mizuno R, Shinoda K, Kikuchi E, et al. Are predictive models for cancer volume clinically useful in localized prostate cancer? Int J Urol 2009
  14. [CrossRef] 14. Stamatakis L, Siddiqui MM, Nix JW, Logan J, Rais-Bahrami S, Walton-Diaz A, et al. Accuracy of multiparametric magnetic reso